Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide + R-mini CHOP in Elderly Newly Diagnosed MYC/BCL2 Co-expressor DLBCL
NCT07493148Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL). Started Apr 2026; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07493148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07493148.